EvoMG Program
@evomg-bcn.bsky.social
The Evolutionary Medical Genomics (EvoMG) Program is a joint initiative by the CRG, UPF and IBE in Barcelona to boost biomedical research by applying evolutionary approaches.
Website: https://t.co/MBCtzyi8jt
Website: https://t.co/MBCtzyi8jt
Today we had a great EvoMG Seminar by Dario Valenzano @dvalenzano.bsky.social from FLI, who told us about some of their recent aging work using the fascinating short-lived killifish.
Hosted by @mirimiam.bsky.social
evomedgenomics.com/events/exter...
Hosted by @mirimiam.bsky.social
evomedgenomics.com/events/exter...
November 5, 2025 at 11:18 PM
Today we had a great EvoMG Seminar by Dario Valenzano @dvalenzano.bsky.social from FLI, who told us about some of their recent aging work using the fascinating short-lived killifish.
Hosted by @mirimiam.bsky.social
evomedgenomics.com/events/exter...
Hosted by @mirimiam.bsky.social
evomedgenomics.com/events/exter...
Reposted by EvoMG Program
1. Map evolutionary diversity to hack biomedical innovation
2. Revolutionize cancer therapy
3. Target the development of antimicrobial resistance
4. Address Anthropocene-related diseases
5. Support healthier behaviors
6. Improve pandemic responses
by Barbara Natterson-Horowitz & Dan Blumstein!
2. Revolutionize cancer therapy
3. Target the development of antimicrobial resistance
4. Address Anthropocene-related diseases
5. Support healthier behaviors
6. Improve pandemic responses
by Barbara Natterson-Horowitz & Dan Blumstein!
6 ways evolutionary medicine can transform our health
Evolutionary medicine is an emerging interdisciplinary field with huge potential to improve human health and tackle a broad scope of major health challenges.
www.weforum.org
November 4, 2025 at 5:03 PM
1. Map evolutionary diversity to hack biomedical innovation
2. Revolutionize cancer therapy
3. Target the development of antimicrobial resistance
4. Address Anthropocene-related diseases
5. Support healthier behaviors
6. Improve pandemic responses
by Barbara Natterson-Horowitz & Dan Blumstein!
2. Revolutionize cancer therapy
3. Target the development of antimicrobial resistance
4. Address Anthropocene-related diseases
5. Support healthier behaviors
6. Improve pandemic responses
by Barbara Natterson-Horowitz & Dan Blumstein!
Reposted by EvoMG Program
“Although drug resistance closes some doors, it can open new ones.”
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
October 23, 2025 at 9:34 AM
“Although drug resistance closes some doors, it can open new ones.”
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
Reposted by EvoMG Program
Are you looking for a PhD? Join us in Barcelona! You'll dive into a community of >100 PhD students from 30 countries exploring the frontiers of biology. You can also join an online workshop on 6 November (15:00 CET) to learn how to find the right lab for you.
More info: www.crg.eu/en/content/t...
More info: www.crg.eu/en/content/t...
October 23, 2025 at 7:56 AM
Are you looking for a PhD? Join us in Barcelona! You'll dive into a community of >100 PhD students from 30 countries exploring the frontiers of biology. You can also join an online workshop on 6 November (15:00 CET) to learn how to find the right lab for you.
More info: www.crg.eu/en/content/t...
More info: www.crg.eu/en/content/t...
Reposted by EvoMG Program
#PhDOffer #AcademicJobs #PhDChat #PhDLife
📣 15 fully funded PhD positions in Evolutionary Medical Genomics (@evomg-bcn.bsky.social) are open!
🧬🔬 Explore ageing, cancer evolution, and pathogen resistance across leading European institutions.
Deadline: Nov 30
Apply here: www.evomg-dn.eu
📣 15 fully funded PhD positions in Evolutionary Medical Genomics (@evomg-bcn.bsky.social) are open!
🧬🔬 Explore ageing, cancer evolution, and pathogen resistance across leading European institutions.
Deadline: Nov 30
Apply here: www.evomg-dn.eu
October 17, 2025 at 11:10 AM
#PhDOffer #AcademicJobs #PhDChat #PhDLife
📣 15 fully funded PhD positions in Evolutionary Medical Genomics (@evomg-bcn.bsky.social) are open!
🧬🔬 Explore ageing, cancer evolution, and pathogen resistance across leading European institutions.
Deadline: Nov 30
Apply here: www.evomg-dn.eu
📣 15 fully funded PhD positions in Evolutionary Medical Genomics (@evomg-bcn.bsky.social) are open!
🧬🔬 Explore ageing, cancer evolution, and pathogen resistance across leading European institutions.
Deadline: Nov 30
Apply here: www.evomg-dn.eu
Reposted by EvoMG Program
Become part of a Marie Skłodowska-Curie Doctoral Network a prestigious EU initiative offering world-class research training, international experience, and strong career prospects for early-stage researchers.
It’s more than a PhD:it’s a launchpad for your research career!
Apply now: www.evomg-dn.eu
It’s more than a PhD:it’s a launchpad for your research career!
Apply now: www.evomg-dn.eu
October 16, 2025 at 2:26 PM
Become part of a Marie Skłodowska-Curie Doctoral Network a prestigious EU initiative offering world-class research training, international experience, and strong career prospects for early-stage researchers.
It’s more than a PhD:it’s a launchpad for your research career!
Apply now: www.evomg-dn.eu
It’s more than a PhD:it’s a launchpad for your research career!
Apply now: www.evomg-dn.eu
Reposted by EvoMG Program
Become part of a Marie Skłodowska-Curie Doctoral Network a prestigious EU initiative offering world-class research training, international experience, and strong career prospects for early-stage researchers.
It’s more than a PhD:it’s a launchpad for your research career!
Apply now: www.evomg-dn.eu
It’s more than a PhD:it’s a launchpad for your research career!
Apply now: www.evomg-dn.eu
October 17, 2025 at 7:34 AM
Reposted by EvoMG Program
At the @melisupf.bsky.social, @mirimiam.bsky.social would like to recruit two fully-funded #PhDcandidate for the #MSCA Doctoral Network @evomg-dn.bsky.social.
#AcademicSky #ResearchJobs
#AcademicSky #ResearchJobs
🚨🚨🚨
Two super well-funded PhD grants from our MSCA Doctoral Network @evomg-dn.bsky.social at our lab at @melisupf.bsky.social, @crg.eu and the @evomg-bcn.bsky.social Program.
If you're excited about evolution, genomics and biomedical research, this is your DN! 😃
Further info: www.evomg-dn.eu and 👇
Two super well-funded PhD grants from our MSCA Doctoral Network @evomg-dn.bsky.social at our lab at @melisupf.bsky.social, @crg.eu and the @evomg-bcn.bsky.social Program.
If you're excited about evolution, genomics and biomedical research, this is your DN! 😃
Further info: www.evomg-dn.eu and 👇
EVOMG-DN
EvoMG-DN is a European Doctoral Network funded by the Horizon Europe Marie Skłodowska-Curie Actions (MSCA), composed of 14 beneficiaries and associated partners from both academic and non-academic sectors.
www.evomg-dn.eu
October 15, 2025 at 11:09 AM
At the @melisupf.bsky.social, @mirimiam.bsky.social would like to recruit two fully-funded #PhDcandidate for the #MSCA Doctoral Network @evomg-dn.bsky.social.
#AcademicSky #ResearchJobs
#AcademicSky #ResearchJobs
Reposted by EvoMG Program
🚨🚨🚨
Two super well-funded PhD grants from our MSCA Doctoral Network @evomg-dn.bsky.social at our lab at @melisupf.bsky.social, @crg.eu and the @evomg-bcn.bsky.social Program.
If you're excited about evolution, genomics and biomedical research, this is your DN! 😃
Further info: www.evomg-dn.eu and 👇
Two super well-funded PhD grants from our MSCA Doctoral Network @evomg-dn.bsky.social at our lab at @melisupf.bsky.social, @crg.eu and the @evomg-bcn.bsky.social Program.
If you're excited about evolution, genomics and biomedical research, this is your DN! 😃
Further info: www.evomg-dn.eu and 👇
EVOMG-DN
EvoMG-DN is a European Doctoral Network funded by the Horizon Europe Marie Skłodowska-Curie Actions (MSCA), composed of 14 beneficiaries and associated partners from both academic and non-academic sectors.
www.evomg-dn.eu
October 15, 2025 at 7:02 AM
🚨🚨🚨
Two super well-funded PhD grants from our MSCA Doctoral Network @evomg-dn.bsky.social at our lab at @melisupf.bsky.social, @crg.eu and the @evomg-bcn.bsky.social Program.
If you're excited about evolution, genomics and biomedical research, this is your DN! 😃
Further info: www.evomg-dn.eu and 👇
Two super well-funded PhD grants from our MSCA Doctoral Network @evomg-dn.bsky.social at our lab at @melisupf.bsky.social, @crg.eu and the @evomg-bcn.bsky.social Program.
If you're excited about evolution, genomics and biomedical research, this is your DN! 😃
Further info: www.evomg-dn.eu and 👇
Reposted by EvoMG Program
We’re proud to introduce the Principal Investigators leading the EvoMG Doctoral Network, an international team guiding and mentoring the next generation of evolutionary medicine researchers.
Discover more about their work and the PhD opportunities 👇
www.evomg-dn.eu
Discover more about their work and the PhD opportunities 👇
www.evomg-dn.eu
October 13, 2025 at 9:19 AM
We’re proud to introduce the Principal Investigators leading the EvoMG Doctoral Network, an international team guiding and mentoring the next generation of evolutionary medicine researchers.
Discover more about their work and the PhD opportunities 👇
www.evomg-dn.eu
Discover more about their work and the PhD opportunities 👇
www.evomg-dn.eu
Reposted by EvoMG Program
📢 EvoMG-DN PhD applications are now open!
Join our EU-funded MSCA network and explore evolution, ageing, and disease.
👉 www.evomg-dn.eu
📅 Apply by 30 November 2025
#PhD #DoctoralTraining #MSCA #HorizonEurope #Genomics #EvolutionaryBiology #BiomedicalResearch#EarlyCareerResearchers
Join our EU-funded MSCA network and explore evolution, ageing, and disease.
👉 www.evomg-dn.eu
📅 Apply by 30 November 2025
#PhD #DoctoralTraining #MSCA #HorizonEurope #Genomics #EvolutionaryBiology #BiomedicalResearch#EarlyCareerResearchers
October 7, 2025 at 8:28 AM
📢 EvoMG-DN PhD applications are now open!
Join our EU-funded MSCA network and explore evolution, ageing, and disease.
👉 www.evomg-dn.eu
📅 Apply by 30 November 2025
#PhD #DoctoralTraining #MSCA #HorizonEurope #Genomics #EvolutionaryBiology #BiomedicalResearch#EarlyCareerResearchers
Join our EU-funded MSCA network and explore evolution, ageing, and disease.
👉 www.evomg-dn.eu
📅 Apply by 30 November 2025
#PhD #DoctoralTraining #MSCA #HorizonEurope #Genomics #EvolutionaryBiology #BiomedicalResearch#EarlyCareerResearchers
Reposted by EvoMG Program
The second is about potential fitness costs of cancer drug resistance, and how we might exploit them using approaches like adaptive therapy. (building on our work with @mlockley.bsky.social in ovarian cancer: aacrjournals.org/cancerres/ar...). Description here: www.icr.ac.uk/study-and-ca...
Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control
Carboplatin adaptive therapy improves treatment efficacy without increasing daily dose due to reduced fitness of drug-resistant populations, which can be tracked using cfDNA and could direct adaptive ...
aacrjournals.org
October 14, 2025 at 8:26 PM
The second is about potential fitness costs of cancer drug resistance, and how we might exploit them using approaches like adaptive therapy. (building on our work with @mlockley.bsky.social in ovarian cancer: aacrjournals.org/cancerres/ar...). Description here: www.icr.ac.uk/study-and-ca...
Reposted by EvoMG Program
We have two fantastically well-funded #PhD studentships available through the @evomg-dn.bsky.social #EU doctoral network (led by brilliant @mirimiam.bsky.social, @crg.eu). These enable students to move to the UK and come and work with us @icr.ac.uk to exploit #cancer #evolution for patient benefit.
October 14, 2025 at 8:21 PM
We have two fantastically well-funded #PhD studentships available through the @evomg-dn.bsky.social #EU doctoral network (led by brilliant @mirimiam.bsky.social, @crg.eu). These enable students to move to the UK and come and work with us @icr.ac.uk to exploit #cancer #evolution for patient benefit.
Reposted by EvoMG Program
Las week, the @prbb.org hosted the Iberian EvoMG PI Meeting 2025. An event organized by the @evomg-bcn.bsky.social & @biomics-twinning.bsky.social to bring together all researchers working on the different areas of evolutionary medical genomics.
Delighted to see so many familiar faces there! 🙌😊
Delighted to see so many familiar faces there! 🙌😊
Next was Juan Diez ( @viroupf.bsky.social ), from the EvoMG Program and @melisupf.bsky.social, on virus projects involving virus evolution and host-viral interactions.
October 13, 2025 at 8:29 AM
Las week, the @prbb.org hosted the Iberian EvoMG PI Meeting 2025. An event organized by the @evomg-bcn.bsky.social & @biomics-twinning.bsky.social to bring together all researchers working on the different areas of evolutionary medical genomics.
Delighted to see so many familiar faces there! 🙌😊
Delighted to see so many familiar faces there! 🙌😊
And the last session of the meeting was Session 5: Cancer.
The first speaker was David Posada ( @davidposada.bsky.social ), from the Universidade de Vigo and @cinbio.bsky.social, who showed us how somatic phylogenetics can provide fundamental insights into the evolutionary dynamics of cancer.
The first speaker was David Posada ( @davidposada.bsky.social ), from the Universidade de Vigo and @cinbio.bsky.social, who showed us how somatic phylogenetics can provide fundamental insights into the evolutionary dynamics of cancer.
October 12, 2025 at 4:04 PM
And the last session of the meeting was Session 5: Cancer.
The first speaker was David Posada ( @davidposada.bsky.social ), from the Universidade de Vigo and @cinbio.bsky.social, who showed us how somatic phylogenetics can provide fundamental insights into the evolutionary dynamics of cancer.
The first speaker was David Posada ( @davidposada.bsky.social ), from the Universidade de Vigo and @cinbio.bsky.social, who showed us how somatic phylogenetics can provide fundamental insights into the evolutionary dynamics of cancer.
In between Sessions 4 (aging) and 5 (cancer), we had the perfect bridge between the two topics, with the second keynote talk, by Iñigo Martincorena (@imartincorena.bsky.social), who told us about their work on somatic evolution, and its implications for aging and cancer.
October 12, 2025 at 3:53 PM
In between Sessions 4 (aging) and 5 (cancer), we had the perfect bridge between the two topics, with the second keynote talk, by Iñigo Martincorena (@imartincorena.bsky.social), who told us about their work on somatic evolution, and its implications for aging and cancer.
The last day (Fri 10/10) started with Session 4: Aging and related diseases.
October 12, 2025 at 3:50 PM
The last day (Fri 10/10) started with Session 4: Aging and related diseases.
And after the round table, we continued Session 3 on microbes, microbiome and antibiotic resistance, with Maria Isabel Veiga, from @icvs-uminho.bsky.social , who talked about drug resistance in malaria.
October 12, 2025 at 3:12 PM
And after the round table, we continued Session 3 on microbes, microbiome and antibiotic resistance, with Maria Isabel Veiga, from @icvs-uminho.bsky.social , who talked about drug resistance in malaria.
After the coffee break, we had a round table about dealing with evolution of drug resistance & synergies among EvoMG fields. We had a panel representing the different related "areas": Isabel Veiga (Plasmodium), David Posada (Cancer), Jero Rodriguez (Bacteria), Ana Abecasis (Virus).
October 12, 2025 at 2:56 PM
After the coffee break, we had a round table about dealing with evolution of drug resistance & synergies among EvoMG fields. We had a panel representing the different related "areas": Isabel Veiga (Plasmodium), David Posada (Cancer), Jero Rodriguez (Bacteria), Ana Abecasis (Virus).
Session 3 (Thr 09/10 in the afternoon) was dedicated to Microbes, microbiome and antibiotic resistance.
October 12, 2025 at 2:53 PM
Session 3 (Thr 09/10 in the afternoon) was dedicated to Microbes, microbiome and antibiotic resistance.
After the lunch break, Teresa M. Coque (@tmcoque.bsky.social), from the Hospital Universitario Ramón y Cajal (IRYCIS) gave us a special talk with her EvoMG view from the hospital. A historical and conceptual perspective on disease evolution and its co-evolution with society's ways to tackle it.
October 12, 2025 at 2:35 PM
After the lunch break, Teresa M. Coque (@tmcoque.bsky.social), from the Hospital Universitario Ramón y Cajal (IRYCIS) gave us a special talk with her EvoMG view from the hospital. A historical and conceptual perspective on disease evolution and its co-evolution with society's ways to tackle it.
After the coffee break, we continued with the Session 2b: Genomic basis & history of disease.
The first speaker was Sandra Acosta ( @sacostav.bsky.social ), also from @ub.edu, who told us about her work inferring the role of conserved regulatory elements in human brain development & disease
The first speaker was Sandra Acosta ( @sacostav.bsky.social ), also from @ub.edu, who told us about her work inferring the role of conserved regulatory elements in human brain development & disease
October 12, 2025 at 2:08 PM
After the coffee break, we continued with the Session 2b: Genomic basis & history of disease.
The first speaker was Sandra Acosta ( @sacostav.bsky.social ), also from @ub.edu, who told us about her work inferring the role of conserved regulatory elements in human brain development & disease
The first speaker was Sandra Acosta ( @sacostav.bsky.social ), also from @ub.edu, who told us about her work inferring the role of conserved regulatory elements in human brain development & disease
The second session (Thr 09/10, morning) was dedicated to the Genomic Basis & History of Disease.
October 12, 2025 at 1:48 PM
The second session (Thr 09/10, morning) was dedicated to the Genomic Basis & History of Disease.
The first session of the Iberian EvoMG PI meeting was on "Virus, transposable elements & biotechnology". 🦠🧬
The first speaker was Ana Abecasis from NOVA University of Lisbon, on HIV-1 transmission and evolution.
The first speaker was Ana Abecasis from NOVA University of Lisbon, on HIV-1 transmission and evolution.
October 12, 2025 at 9:10 AM
The first session of the Iberian EvoMG PI meeting was on "Virus, transposable elements & biotechnology". 🦠🧬
The first speaker was Ana Abecasis from NOVA University of Lisbon, on HIV-1 transmission and evolution.
The first speaker was Ana Abecasis from NOVA University of Lisbon, on HIV-1 transmission and evolution.
Opening keynote talk by Pedro Beltrão on the genetics of human trait variation across the scales of biological organization.
October 8, 2025 at 1:55 PM
Opening keynote talk by Pedro Beltrão on the genetics of human trait variation across the scales of biological organization.